Chronic treatment with inhaled corticosteroids does not modify leptin serum levels

Giorgio Radetti, C. Paganini, P. S. Morpurgo, L. Pescollderungg, P. Beck-Peccoz

Research output: Contribution to journalArticlepeer-review


Aim: To assess the influence of a short-term treatment with low-dose inhaled corticosteroids on leptin serum levels. Patients: 14 prepubertal children, mean age 5.1 ± 2.4 years, treated with inhaled fluticasone propionate 100 μg b.d. and 16 prepubertal children, mean age 8.3 ± 1.3 years, treated with inhaled budesonide 200 μg b.d. Methods: All children underwent a CRH test with evaluation of leptin, cortisol and ACTH levels before and after 3 months of treatment. Results: Fluticasone group: no difference was found between basal cortisol level, delta and area under the curve (AUC) before and after treatment, though cortisol peak was significantly lower following treatment. Basal ACTH level, peak and AUC were significantly lower after treatment. Budesonide group: no statistically significant difference in any of the parameters regarding cortisol and ACTH secretion was observed before and after treatment. No significant changes in basal serum leptin levels and AUC were observed following treatment in both groups. Furthermore no significant variation in leptin level was observed during both CRH tests. Discussion: Leptin secretion does not seem to be affected by low-dose inhaled corticosteroids; moreover leptin does not seem to be involved in the response of the HPA axis to stress.

Original languageEnglish
Pages (from-to)77-79
Number of pages3
JournalExperimental and Clinical Endocrinology and Diabetes
Issue number2
Publication statusPublished - Apr 2003


  • Asthma
  • Children
  • Cortisol
  • CRH

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Chronic treatment with inhaled corticosteroids does not modify leptin serum levels'. Together they form a unique fingerprint.

Cite this